Philipp Holliger and Ben Porebski in the LMB’s PNAC Division, in collaboration with AstraZeneca, have developed a new ultra-high-throughput method that shows promise to accelerate antibody discovery for a wide range of targets.
New deep screening technique enables rapid discovery of high-affinity antibodies to clinically relevant drug targets
New method to untangle the contribution of signalling pathways involved in asymmetric cell division
First Cryo-EM structures of homomeric GluA1 AMPA glutamate receptor reveals functional roles for N-terminal domains
Electron cryo-microscopy structures of GluA1 AMPA receptors from Ingo Greger’s group in the LMB’s Neurobiology Division reveals that previously unseen structural flexibility of N-terminal domains is crucial for regulating the open-close speed of ion channel gates and recruiting the receptor into synapses.